These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42 related articles for article (PubMed ID: 2226262)
1. [The hormonal sensitivity of a transplantable adenocarcinoma of the large intestine]. Bershteĭn LM; Zabezhinskiĭ MA; Stukov AN; Kalikhevich VN; Mikheev AM Eksp Onkol; 1990; 12(5):62-4. PubMed ID: 2226262 [TBL] [Abstract][Full Text] [Related]
2. [The assessment of the hormonal sensitivity of tumors of the large intestine in the adenylate cyclase test]. Bershteĭn LM; Pravosudov IV; Kovaleva IG; Kriukova OG Vopr Onkol; 1992; 38(1):60-9. PubMed ID: 1300689 [TBL] [Abstract][Full Text] [Related]
3. Hormonal regulation of adenylate cyclase activity in circulating lymphocytes and its interrelationship with hormone sensitivity of tumor tissue in colorectal cancer patients. Berstein LM; Pravosudov IV; Kryukova OG Neoplasma; 1995; 42(2):57-61. PubMed ID: 7617078 [TBL] [Abstract][Full Text] [Related]
4. Dependence of gastro-intestinal tumors on gastro-intestinal hormones: pentagastrin stimulates growth of transplanted colon adenocarcinoma in mice. Svet-Moldavsky GJ Biomedicine; 1980 Dec; 33(8):259-61. PubMed ID: 7213923 [TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor. Birnbaum RS; Alfonzo M; Kowal J Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149 [TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433 [TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide control of cyclic adenosine 3':5'-monophosphate levels in seven human colorectal adenocarcinoma cell lines in culture. Laburthe M; Rousset M; Chevalier G; Boissard C; Dupont C; Zweibaum A; Rosselin G Cancer Res; 1980 Jul; 40(7):2529-33. PubMed ID: 6248206 [TBL] [Abstract][Full Text] [Related]
8. Effects of proglumide, a gastrin receptor antagonist, on human large intestine carcinoma SW480 cell line. Shen K; He S; He Y Chin Med J (Engl); 1998 Dec; 111(12):1075-8. PubMed ID: 11263367 [TBL] [Abstract][Full Text] [Related]
9. Bone and kidney adenylate cyclase-stimulating activity produced by a hypercalcemic canine adenocarcinoma line (CAC-8) maintained in nude mice. Rosol TJ; Capen CC; Brooks CL Cancer Res; 1987 Feb; 47(3):690-5. PubMed ID: 3467838 [TBL] [Abstract][Full Text] [Related]
10. Xenotransplantation of neoplasias and pharmacological trial. Cabrita AM; Patrício JB; Beja ML Transplant Proc; 1992 Dec; 24(6):3035-7. PubMed ID: 1466045 [No Abstract] [Full Text] [Related]
11. Role of gastrin and gastrin receptors on the growth of a transplantable mouse colon carcinoma (MC-26) in BALB/c mice. Singh P; Walker JP; Townsend CM; Thompson JC Cancer Res; 1986 Apr; 46(4 Pt 1):1612-6. PubMed ID: 3004700 [TBL] [Abstract][Full Text] [Related]
12. [Effect of the joint use of BCG and antithymocyte serum on the growth of a syngeneic tumor in mice]. Babadzhanov AS; Slavina EG Biull Eksp Biol Med; 1983 Feb; 95(2):68-70. PubMed ID: 6600630 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of pentagastrin-stimulated up-regulation of gastrin receptors and growth of mouse colon tumor in vivo by proglumide, a gastrin receptor antagonist. Singh P; Le S; Beauchamp RD; Townsend CM; Thompson JC Cancer Res; 1987 Oct; 47(19):5000-4. PubMed ID: 3621187 [TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes. Mittag TW; Tormay A; Podos SM J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201 [TBL] [Abstract][Full Text] [Related]
15. Peculiarities of hormonal regulation of adenylate cyclase and lipid composition in colonic and rectal tumors. Berstein LM; Kovaleva IG; Pravosudov IV; Dilman VM Neoplasma; 1989; 36(4):465-71. PubMed ID: 2770932 [TBL] [Abstract][Full Text] [Related]
16. Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist. Zia H; Hida T; Jakowlew S; Birrer M; Gozes Y; Reubi JC; Fridkin M; Gozes I; Moody TW Cancer Res; 1996 Aug; 56(15):3486-9. PubMed ID: 8758916 [TBL] [Abstract][Full Text] [Related]
17. Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide. Rekasi Z; Schally AV; Plonowski A; Czompoly T; Csernus B; Varga JL Prostate; 2001 Aug; 48(3):188-99. PubMed ID: 11494334 [TBL] [Abstract][Full Text] [Related]
18. [Immunogenic properties of adenocarcinoma of mouse large intestine]. Avdeev GI; Svet-Moldavskaia IA; Khatuntseva NI; Kovaleva LP Vopr Onkol; 1978; 24(3):72-7. PubMed ID: 644968 [TBL] [Abstract][Full Text] [Related]
19. Growth of colorectal carcinoma cells: regulation in vitro by gastrin, pentagastrin and the gastrin-receptor antagonist proglumide. Imdahl A; Eggstein S; Crone C; Farthmann EH J Cancer Res Clin Oncol; 1989; 115(4):388-92. PubMed ID: 2760104 [TBL] [Abstract][Full Text] [Related]